Other classes of antidepressants are also associated with obesity and metabolic disease53; however, most have some inhibitory action on SERT including tricyclic antidepressants, serotonin and norepinephrine reuptake inhibitors, and trazodone54. Here, SLC6A4 is linked to obesity disorder.